FRONTEO, Inc.
Stock Price Chart
2026/10/02 11:38 UpdatedPrice Trend
2026/10/02 11:38 UpdatedPrice & Trading Details
2026/10/02 11:38 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2019/02/13 | ¥1.28 | ¥-1.43 | -211.7% |
| 2018/11/13 | ¥1.23 | ¥1.22 | -0.8% |
| 2018/08/13 | ¥1.96 | ¥3.66 | +86.7% |
| 2018/05/14 | ¥8.27 | ¥13.87 | +67.7% |
Shareholder Composition
Updated 2026/10/01Dividend History 1Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2022 | ¥7 | +133.3% |
| 2020 | ¥3 | 0.0% |
| 2019 | ¥3 | 0.0% |
| 2016 | ¥3 | 0.0% |
| 2015 | ¥3 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥7,215M | ¥7,375M | ¥6,099M | ¥7,643M |
| Gross Profit | ¥3,261M | ¥3,725M | ¥3,453M | ¥3,906M |
| Operating Income | -¥1,362M | -¥185M | ¥528M | ¥739M |
| Pretax Income | -¥1,680M | -¥2,815M | ¥267M | ¥714M |
| Net Income | -¥1,701M | -¥2,843M | ¥555M | ¥544M |
| EPS | -¥43.27 | -¥72.25 | ¥14.10 | ¥13.86 |
| Operating Margin | -18.88% | -2.51% | 8.65% | 9.67% |
| Balance Sheet | ||||
| Total Assets | ¥9,145M | ¥7,523M | ¥6,467M | ¥9,202M |
| Total Equity | ¥5,050M | ¥2,840M | ¥3,228M | ¥3,845M |
| Total Liabilities | ¥4,095M | ¥4,683M | ¥3,239M | ¥5,358M |
| Cash | ¥1,476M | ¥3,044M | ¥2,599M | ¥1,735M |
| Interest-bearing Debt | ¥3,087M | ¥2,926M | ¥1,987M | ¥4,025M |
| Equity Ratio | 55.22% | 37.75% | 49.91% | 41.78% |
| D/E Ratio | 0.61 | 1.03 | 0.62 | 1.05 |
| Cash Flow | ||||
| Operating CF | -¥915M | ¥1,710M | ¥753M | ¥258M |
| Investing CF | -¥625M | -¥182M | -¥254M | -¥2,486M |
| Financing CF | -¥606M | -¥34M | -¥913M | ¥1,336M |
| Free CF | -¥1,537M | ¥1,230M | ¥469M | -¥568M |
| Efficiency | ||||
| ROE | -33.69% | -100.13% | 17.20% | 14.16% |
| ROA | -18.60% | -37.79% | 8.58% | 5.91% |
Latest IR Information
-
[FRONTEO] Funding for Growth in Life Science AI Business | July 2026
FRONTEO has concluded a total loan contract of 1,220 million yen with Mitsubishi UFJ Bank, Sumitomo Mitsui Banking Corporation, and Resona Bank to accelerate the growth of its life science AI business, promoting business expansion and monetization.
Read more -
June 2026 Earnings Announcement | Details of Revenue, Earnings Guidance, and Business Strategy
For the June 2026 fiscal year, reports detailed revenue, operating income, and net income, and outlines business strategy and outlook, with graphs and charts for detailed explanation.
Read more
Latest News (5 items)
Financials For C3.ai Inc. - Barron's ↗
Company Information
About
FRONTEO, Inc. provides artificial intelligence (AI) solutions and services in Japan and internationally. The company operates through Life science AI Business, Risk Management Business, and DX business segment. It offers e-discovery support and forensic investigation services; KIBIT, a digital forensic software; and forensic tools. The company also offers business intelligence AI products, such as Communication Meter, an email and chat audit system; WordSonar for AccidentView, a system that predicts the disaster risk of construction site; WordSonar for VoiceView, a solution use for customer voices; Knowledge Probe, a business data analysis support system; Patent Explorer, a patent search support system; Q&A system that learns the characteristics of questions and presents the answers; Kibi+-Connect, an API for the artificial intelligence engine; and AI training and support services. In addition, it provides Concept Encoder, an AI algorithm specialized for the healthcare industry; Looca Cross, an AI engine; and economic security AI solutions. The company was formerly known as UBIC, Inc. and changed its name to FRONTEO, Inc. in July 2016. The company was incorporated in 2003 and is headquartered in Tokyo, Japan.
